M. Romero

A. Albillos, R. Malo de Molina, J. García-Samaniego, 2021, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Selection of Hepatitis B Virus (HBV) Vaccine Escape Mutants in HBV-Infected and HBV/HIV-Coinfected Patients Failing Antiretroviral Drugs With Anti-HBV Activity

V. Soriano, F. Zoulim, S. Locarnini, 2007, Journal of acquired immune deficiency syndromes.

Evaluation of initial virological response to adefovir and development of adefovir‐resistant mutations in patients with chronic hepatitis B

V. Soriano, J. Sheldon, J. Enríquez, 2008 .

Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment

R. Mena, A. Olveira, J. García-Samaniego, 2019, World journal of gastroenterology.

Clinical significance of occult hepatitis B virus infection.

C. Fernández-Rodríguez, J. García-Samaniego, A. Madejón, 2011, World journal of gastroenterology.

Impact of Ribavirin Exposure on Early Virological Response to Hepatitis C Therapy in HIV-Infected Patients with Chronic Hepatitis C

V. Soriano, P. Arazo, A. Ocampo, 2005, Antiviral therapy.

Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial.

V. Soriano, P. Arazo, A. Ocampo, 2007, AIDS research and human retroviruses.

Treatment of Chronic Hepatitis C in HIV-Infected Patients with Interferon a-2 b Plus Ribavirin

V. Soriano, M. Pérez-Olmeda, I. Jiménez-Nácher, 2004 .

Hepatitis B and D viruses replication interference: Influence of hepatitis B genotype.

A. Olveira, J. García-Samaniego, A. Madejón, 2016, World journal of gastroenterology.

Hepatitis C Virus-Rna Clearance in HIV-Coinfected Patients with Chronic Hepatitis C Treated with Pegylated Interferon plus Ribavirin

V. Soriano, J. González-lahoz, J. García-Samaniego, 2003, Antiviral therapy.

Association of pretreatment serum interferon γ inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C

M. Diago, C. García-Monzón, I. Fernández, 2005, Gut.

Treatment of Chronic Hepatitis C in HIV-Infected Patients with Interferon α-2b Plus Ribavirin

V. Soriano, M. Pérez-Olmeda, I. Jiménez-Nácher, 2003 .

Response to Interferon-Based Therapies in HIV-Infected Patients with Chronic Hepatitis C Due to Genotype 4

V. Soriano, J. González-lahoz, M. Sánchez-Conde, 2005, Antiviral therapy.

Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV‐coinfected patients

V. Soriano, P. Arazo, A. Ocampo, 2007 .

Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients.

V. Soriano, P. Arazo, A. Ocampo, 2006, Journal of viral hepatitis.

Treatment of chronic hepatitis C in HIV-infected patients with interferon alpha-2b plus ribavirin.

V. Soriano, M. Pérez-Olmeda, I. Jiménez-Nácher, 2003, AIDS research and human retroviruses.

Comparative study of the efficacy of an induction dose of interferon‐α2b with ribavirin compared with standard combined treatment in naive patients with chronic hepatitis C

M. Diago, J. Crespo, L. Rodrigo, 2003, Journal of viral hepatitis.

Virological characteristics of hepatitis C virus infection in HIV-infected individuals with chronic hepatitis C: implications for treatment.

V. Soriano, M. Pérez-Olmeda, J. García-Samaniego, 2002, AIDS.

Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection

J. Foucher, V. Ledinghen, J. García-Samaniego, 2009, Journal of viral hepatitis.